These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
876 related articles for article (PubMed ID: 33447032)
41. Novel anti-arthritic mechanisms of trans-cinnamaldehyde against complete Freund's adjuvant-induced arthritis in mice: involvement of NF-кB/TNF-α and IL-6/IL-23/ IL-17 pathways in the immuno-inflammatory responses. El-Tanbouly GS; Abdelrahman RS Inflammopharmacology; 2022 Oct; 30(5):1769-1780. PubMed ID: 35648328 [TBL] [Abstract][Full Text] [Related]
42. Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box-Behnken statistical design. Salem HF; Kharshoum RM; Sayed OM; Abdel Hakim LF Drug Dev Ind Pharm; 2018 Nov; 44(11):1871-1884. PubMed ID: 30044654 [TBL] [Abstract][Full Text] [Related]
43. Andrographolide ameliorates oxidative stress, inflammation and histological outcome in complete Freund's adjuvant-induced arthritis. Luo S; Li H; Liu J; Xie X; Wan Z; Wang Y; Zhao Z; Wu X; Li X; Yang M; Li X Chem Biol Interact; 2020 Mar; 319():108984. PubMed ID: 32061742 [TBL] [Abstract][Full Text] [Related]
44. The small molecule NSM00191 specifically represses the TNF-α/NF-кB axis in foot and ankle rheumatoid arthritis. Wen X; Chen X; Liang X; Zhao H; Li Y; Sun X; Lu J Int J Biol Sci; 2018; 14(12):1732-1744. PubMed ID: 30416388 [TBL] [Abstract][Full Text] [Related]
45. Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights. Janakiraman K; Krishnaswami V; Rajendran V; Natesan S; Kandasamy R Mater Today Commun; 2018 Dec; 17():200-213. PubMed ID: 32289062 [TBL] [Abstract][Full Text] [Related]
46. Polystichum braunii extracts inhibit Complete Freund's adjuvant-induced arthritis via upregulation of I-κB, IL-4, and IL-10, downregulation of COX-2, PGE2, IL-1β, IL-6, NF-κB, and TNF-α, and subsiding oxidative stress. Saleem A; Saleem M; Akhtar MF; Shahzad M; Jahan S Inflammopharmacology; 2020 Dec; 28(6):1633-1648. PubMed ID: 32162074 [TBL] [Abstract][Full Text] [Related]
47. In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application. Dasgupta S; Ghosh SK; Ray S; Kaurav SS; Mazumder B Curr Drug Deliv; 2014; 11(1):132-8. PubMed ID: 24266509 [TBL] [Abstract][Full Text] [Related]
48. Polymyxin B prevents the development of adjuvant arthritis via modulation of TLR/Cox-2 signaling pathway. Gowayed MA; El Achy S; Kamel MA; El-Tahan RA Life Sci; 2020 Oct; 259():118250. PubMed ID: 32791152 [TBL] [Abstract][Full Text] [Related]
49. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s). Negi P; Aggarwal M; Sharma G; Rathore C; Sharma G; Singh B; Katare OP Biomed Pharmacother; 2017 Apr; 88():480-487. PubMed ID: 28126673 [TBL] [Abstract][Full Text] [Related]
50. Targeting NF-κΒ and TNF-α Activation by Electroacupuncture to Suppress Collagen-induced Rheumatoid Arthritis in Model Rats. Li J; Li J; Chen R; Cai G Altern Ther Health Med; 2015; 21(4):26-34. PubMed ID: 26030114 [TBL] [Abstract][Full Text] [Related]
51. Deformable Liposomal Hydrogel for Dermal and Transdermal Delivery of Meloxicam. Zhang ZJ; Osmałek T; Michniak-Kohn B Int J Nanomedicine; 2020; 15():9319-9335. PubMed ID: 33262590 [TBL] [Abstract][Full Text] [Related]
52. Xanthorrhizol Ameliorates Oxidative Stress and Inflammation in Freund's Complete Adjuvant-Induced Rheumatoid Arthritis in Rats. Zhou M; Li Y; Hou H; Zou W; Hu L; Gong L; Fan W; Wang R; Ibrahim IAA; Fan S Appl Biochem Biotechnol; 2022 Dec; 194(12):6423-6437. PubMed ID: 35932370 [TBL] [Abstract][Full Text] [Related]
53. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis. Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244 [TBL] [Abstract][Full Text] [Related]
54. Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole: Nemr AA; El-Mahrouk GM; Badie HA J Liposome Res; 2022 Jun; 32(2):159-171. PubMed ID: 33970754 [TBL] [Abstract][Full Text] [Related]
56. Synergistically engineered nanotransethosomes for co-delivery of methotrexate and baicalin for enhanced transdermal delivery against rheumatoid arthritis: formulation, characterisation and in vivo pharmacodynamic evaluation. Adin SN; Gupta I; Aqil M; Mujeeb M; Najmi AK J Drug Target; 2024 Jul; 32(6):707-723. PubMed ID: 38652489 [No Abstract] [Full Text] [Related]
57. Formulation of Nanospanlastics as a Promising Approach for Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-Acetyl-11-Keto-β-Boswellic Acid): Statistical Optimization, in vitro Characterization, and ex vivo Permeation Study. Badria F; Mazyed E Drug Des Devel Ther; 2020; 14():3697-3721. PubMed ID: 32982176 [TBL] [Abstract][Full Text] [Related]
58. Rhoifolin regulates oxidative stress and proinflammatory cytokine levels in Freund's adjuvant-induced rheumatoid arthritis via inhibition of NF-κB. Peng S; Hu C; Liu X; Lei L; He G; Xiong C; Wu W Braz J Med Biol Res; 2020; 53(6):e9489. PubMed ID: 32401927 [TBL] [Abstract][Full Text] [Related]
59. Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery. Jain SK; Gupta Y; Jain A; Bhola M Drug Deliv; 2007 Aug; 14(6):327-35. PubMed ID: 17701522 [TBL] [Abstract][Full Text] [Related]
60. Formulation development of self-nanoemulsifying drug delivery system of celecoxib for the management of oral cavity inflammation. Salem HF; Kharshoum RM; Sayed OM; Abdel Hakim LF J Liposome Res; 2019 Jun; 29(2):195-205. PubMed ID: 30221598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]